We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Healx

News List

Healx secures option to license rights from Ovid to develop gaboxadol pharmaceutical-business-review
February 09, 2022
Healx, an AI-powered, technology company involved in the next generation of drug discovery...
Healx links with CTF to develop neurofibromatosis therapies pharmatimes
April 16, 2020
Cambridge, UK-based Healx has formed a new partnership with US and Europe-based patient group the Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF).
Boehringer partners with Healx for AI-based drug discovery pharmaceutical-technology
December 11, 2019
German pharmaceutical company Boehringer Ingelheim has partnered with UK-based drug technology firm Healx to identify approaches to treat rare neurological disorders.
Healx reels in $10M in series A funding for work on rare diseases fiercebiotech
July 31, 2018
Healx, a U.K.-based company that works with patient advocacy groups to repurpose drugs for rare diseases, reeled in $10 million in series A funding it plans to use to hire more researchers and enhance its AI platform.